PodParley PodParley
GPH 62: Cardiovascular Disease

EPISODE · Mar 26, 2026 · 50 MIN

GPH 62: Cardiovascular Disease

from Clinical Deep Dives · host Dr Manaan Kar Ray

Cardiovascular disease (CVD) remains the leading cause of death globally. Yet unlike outbreaks or epidemics that command immediate alarm, CVD progresses quietly - built over decades through patterns of behaviour, biology, and inequality.In this episode of Medlock Holmes: Global Public Health, Holmes turns his attention to the slow-burning architecture of chronic disease.We explore:• Global burden and epidemiological transition• Coronary heart disease, stroke, and heart failure• Modifiable risk factors - tobacco, diet, physical inactivity, hypertension, diabetes• Non-modifiable determinants - age, genetics, sex• Social gradients and inequity• Population vs high-risk strategies• Prevention across the life course• Policy-level interventions and structural preventionHolmes traces how cardiovascular disease shifted from a condition of affluence to a global pandemic affecting low- and middle-income countries disproportionately.This episode examines the tension between individual responsibility and environmental design - between choice and context.Public health success in CVD is rarely dramatic. It is measured in reduced salt intake, tobacco taxation, better primary care, improved lipid control, and incremental gains in survival.The detective story here is long-term. The culprit is cumulative exposure.────────────────────────────Key Takeaways• Cardiovascular disease is the leading global cause of mortality• Risk accumulates over time through behavioural and social determinants• Prevention requires both individual and population-level strategies• Structural policies (taxation, regulation, urban design) significantly influence outcomes• Inequality plays a central role in cardiovascular burden• Early-life exposures shape adult cardiovascular risk This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe

NOW PLAYING

GPH 62: Cardiovascular Disease

0:00 50:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Oncology Today with Dr Neil Love Research To Practice Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice. My Take On It with Your Angelic Karma® Your Angelic Karma Here we take a look at how the United States measures alongside other First World Nations. + taking a deep dive into the science -The Report Metagenics Institute Podcast Metagenics Welcome to the Metagenics Institute Podcast where Healthcare Practitioners can hear innovative, cutting-edge information from leading experts from around the world. Join your host, Nathan Rose, to explore the latest evidence in Natural Health, challenge and debunk industry myths and offer practical, tangible, clinical tools which will transform your practice. The Syndicate Blogcast: Startups | Startup Investing | Tech News | Angel Investors | VC | Venture Capital | Private Equity | Crowdfunding | Fundraising Matt Ward - Serial Entrepreneur | Angel Investor | Startup Advisor | Amazon Ecommerce The Syndicate Blogcast show is an extension of The Syndicate podcast, featuring long form articles on the future technology, ecommerce, business and life. The mini-sodes deconstruct high level startup, business and tech issues to help investors and operators better understand and win the market. Recurring topics include: Facebook, Google, Amazon, Apple, Ecommerce, Blockchains, ICOs, Cryptocurrencies, Marketing, Fundraising, Venture Capital, Startup Challenges, Business Development and more. The Blogcast comes in addition to The Syndicate - the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing.
URL copied to clipboard!